NCT03145181 Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03067155 CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. Status COMPLETED Phase PHASE2
NCT02931110 Study of IV CBL0137 in Previously Treated Hematological Subjects Status TERMINATED Phase PHASE1
NCT02859623 Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN) Status COMPLETED Phase N/A
NCT02849886 T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation. Status TERMINATED Phase PHASE1/PHASE2
NCT02828878 Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation Status UNKNOWN Phase PHASE1/PHASE2
NCT02824159 Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib Status COMPLETED Phase N/A
NCT02730299 Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS Status COMPLETED Phase PHASE3
NCT02680795 Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes Status COMPLETED Phase PHASE1
NCT02611063 Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant Status COMPLETED Phase PHASE1
NCT02576496 Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT02528682 MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT Status COMPLETED Phase PHASE1/PHASE2
NCT02300571 Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant Status UNKNOWN Phase N/A
NCT02269592 Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome Status RECRUITING Phase N/A
NCT02213822 Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis Status UNKNOWN Phase N/A